Investors / New Zealand / Matū
Matū
Venture capital · New Zealand · Asia Pacific
Matū operates venture capital funds that invest in science and deep tech start-ups in Aotearoa New Zealand. It takes a hands-on approach, providing portfolio companies with governance, executive management, operational support and mentorship.
Invests inHealthcare & BiotechIndustrial & ManufacturingFood & Agriculture
In its own wordsdeep techscienceintellectual propertynew zealandearly stageventure capital
Your fit with Matū
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsMatū lists 11 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (50%), Industrial & Manufacturing (25%) and Food & Agriculture (17%). 80% of its companies are based in New Zealand. It invests most often alongside New Zealand Growth Capital Partners, Creative Destruction Lab and WNT Ventures.
No funding round on record names Matū yet, so the figures come from its portfolio page.
Round figures show recent activity, not Matū's whole history. Rounds on record name 0 companies; its own site lists 11. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 27th | 11 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 85th | 50% in its largest sector |
| Reach | 42th | 2 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers11100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 50% | 15% |
| Industrial & Manufacturing | 25% | 7% |
| Food & Agriculture | 17% | 3% |
| Climate & Energy | 8% | 1% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with New Zealand Growth Capital Partners
Compare Matū head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
11 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Advemto accelerates drug development by measuring cell function at library scale using pooled functional screening on a consumable product | Healthcare & Biotech | Portfolio page | ||
| Alimetry develops a non-invasive system that measures the electrical activity of the stomach to guide patient care for chronic gastric symptoms. | Healthcare & Biotech | Portfolio page | ||
| Amaea provides wine filtration and fining solutions to winemakers | Food & Agriculture | Portfolio page | ||
| Portfolio page | ||||
| Captivate Technology develops and implements gas separation and carbon capture technology using advanced adsorbent materials and process engineering. | Industrial & ManufacturingClimate & Energy | Portfolio page | ||
| Portfolio page | ||||
| Ferronova develops a surgical oncology tracer system to improve treatment guidance and staging of complex cancers | Healthcare & Biotech | Portfolio page | ||
| Inhibit Coatings develops and provides antimicrobial coatings for various applications, including healthcare, food processing, and public spaces. | Healthcare & BiotechIndustrial & Manufacturing | Portfolio page | ||
| Liquium is revolutionising the ammonia production process | Industrial & Manufacturing | Portfolio page | ||
| Opo Bio develops cosmetic ingredients and cell lines for research and commercial use | Healthcare & BiotechFood & Agriculture | Portfolio page | ||
| RosterLab generates fair, compliant staff rosters in minutes with AI that balances rules, skills, and preferences at once for healthcare teams. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- matu.co.nz
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Companies checked
- 11
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Matū's profile as data
Pull Matū's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/matu.co.nz
# also
GET /v1/firms/matu.co.nz/portfolio
GET /v1/firms/matu.co.nz/coinvestors
GET /v1/firms/matu.co.nz/news